Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat

23Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Introduction. A pharmacokinetic (PK) model is proposed for estimation of total and free brain concentrations of fluvoxamine. Materials and methods. Rats with arterial and venous cannulas and a microdialysis probe in the frontal cortex received intravenous infusions of 1, 3.7 or 7.3 mg.kg-1 of fluvoxamine. Analysis. With increasing dose a disproportional increase in brain concentrations was observed. The kinetics of brain distribution was estimated by simultaneous analysis of plasma, free brain ECF and total brain tissue concentrations. The PK model consists of three compartments for fluvoxamine concentrations in plasma in combination with a catenary two compartment model for distribution into the brain. In this catenary model, the mass exchange between a shallow perfusion-limited and a deep brain compartment is described by a passive diffusion term and a saturable active efflux term. Results. The model resulted in precise estimates of the parameters describing passive influx into (k in) of 0.16 min-1 and efflux from the shallow brain compartment (k out) of 0.019 min-1 and the fluvoxamine concentration at which 50% of the maximum active efflux (C 50) is reached of 710 ng.ml-1. The proposed brain distribution model constitutes a basis for precise characterization of the PK-PD correlation of fluvoxamine by taking into account the non-linearity in brain distribution. © 2007 Springer Science+Business Media, LLC.

References Powered by Scopus

Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

5348Citations
N/AReaders
Get full text

Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs

560Citations
N/AReaders
Get full text

Inhibition of P-glycoprotein by newer antidepressants

293Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research

241Citations
N/AReaders
Get full text

Brain exposure of two selective dual CDK4 and CDK6 inhibitors and the antitumor activity of CDK4 and CDK6 inhibition in combination with temozolomide in an intracranial glioblastoma xenograft

227Citations
N/AReaders
Get full text

Physiologically-Based Pharmacokinetic (PBPK) Modeling and Simulations: Principles, Methods, and Applications in the Pharmaceutical Industry

135Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Geldof, M., Freijer, J., Van Beijsterveldt, L., & Danhof, M. (2008). Pharmacokinetic modeling of non-linear brain distribution of fluvoxamine in the rat. Pharmaceutical Research, 25(4), 792–804. https://doi.org/10.1007/s11095-007-9390-5

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

56%

Researcher 7

39%

Professor / Associate Prof. 1

6%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 7

37%

Agricultural and Biological Sciences 5

26%

Medicine and Dentistry 5

26%

Chemistry 2

11%

Save time finding and organizing research with Mendeley

Sign up for free